Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Savara Inc | 889,926 | reported | 20 Jan 2017 | tx 12+3,707,626 |
| Lineage Cell Therapeutics, Inc. | 616,700 | reported | 17 Mar 2020 | tx 4+1,271,700 |
| Definium Therapeutics, Inc. | 150,000 | reported | 03 Feb 2026 | tx 2+650,000 |
| REVA Medical, Inc. | 54,907.9 | reported | 29 Jun 2018 | tx 4+344,907.9 |
| TFF Pharmaceuticals, Inc. | 23,165 | reported | 03 Jul 2024 | tx 6+105,489 |
| Longboard Pharmaceuticals, Inc. | 0 | reported | 02 Dec 2024 | tx 11+323,270−462,650 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 03 Feb 2026 | GRANT_AWARD | Definium Therapeutics, Inc. | 150,000 | 0.00 USD | |
| 02 Jun 2025 | GRANT_AWARD | Definium Therapeutics, Inc. | 500,000 | 0.00 USD | deriv |
| 02 Dec 2024 | OTHER | Longboard Pharmaceuticals, Inc. | 7,900 | — | deriv |
| 02 Dec 2024 | OTHER | Longboard Pharmaceuticals, Inc. | 139,380 | — | deriv |
| 02 Dec 2024 | OTHER | Longboard Pharmaceuticals, Inc. | 90,000 | — | deriv |
| 02 Dec 2024 | OTHER | Longboard Pharmaceuticals, Inc. | 119,700 | — | deriv |
| 02 Dec 2024 | OTHER | Longboard Pharmaceuticals, Inc. | 90,580 | — | deriv |
| 02 Dec 2024 | OTHER | Longboard Pharmaceuticals, Inc. | 15,090 | — | deriv |
| 25 Oct 2024 | GRANT_AWARD | Longboard Pharmaceuticals, Inc. | 7,900 | 0.00 USD | deriv |
| 03 Jul 2024 | GRANT_AWARD | TFF Pharmaceuticals, Inc. | 3,165 | 0.00 USD | |
| 03 Jul 2024 | GRANT_AWARD | TFF Pharmaceuticals, Inc. | 3,165 | 0.00 USD | deriv |
| 18 Apr 2024 | GRANT_AWARD | TFF Pharmaceuticals, Inc. | 5,333 | 0.00 USD | deriv |
| 08 Feb 2024 | GRANT_AWARD | Longboard Pharmaceuticals, Inc. | 15,090 | 0.00 USD | |
| 08 Feb 2024 | GRANT_AWARD | Longboard Pharmaceuticals, Inc. | 90,580 | 0.00 USD | deriv |
| 01 Dec 2023 | GRANT_AWARD | TFF Pharmaceuticals, Inc. | 52,858 | 0.00 USD | deriv |
| 15 Aug 2023 | PURCHASE | TFF Pharmaceuticals, Inc. | 20,000 | 0.25 USD | first after silence |
| 09 Feb 2023 | GRANT_AWARD | Longboard Pharmaceuticals, Inc. | 119,700 | 0.00 USD | deriv |
| 29 Dec 2022 | GRANT_AWARD | TFF Pharmaceuticals, Inc. | 20,968 | 0.00 USD | deriv |
| 09 Feb 2022 | GRANT_AWARD | Longboard Pharmaceuticals, Inc. | 90,000 | 0.00 USD | deriv |
| 17 Mar 2020 | GRANT_AWARD | Lineage Cell Therapeutics, Inc. | 616,700 | 0.00 USD | deriv |
| 13 Aug 2019 | PURCHASE | Lineage Cell Therapeutics, Inc. | 5,000 | 1.01 USD | first after silence |
| 30 Jun 2019 | GRANT_AWARD | Lineage Cell Therapeutics, Inc. | 150,000 | 0.00 USD | deriv |
| 07 Jan 2019 | GRANT_AWARD | Lineage Cell Therapeutics, Inc. | 500,000 | 0.00 USD | deriv |
| 29 Jun 2018 | PURCHASE | REVA Medical, Inc. | 4,907.9 | 1.53 USD | first after silence |
| 22 Jan 2018 | GRANT_AWARD | REVA Medical, Inc. | 50,000 | 0.00 USD |
3 purchases reported after at least 12 months of silence — most recent on 15 Aug 2023.